DNA, Rewritten Where It Lives
For the first time, a high-precision gene-editing technique called prime editing has been used to rewrite DNA directly inside a person's body — a first for medicine, but the start of an experiment, not a proven treatment.
The trial is run by Prime Medicine, a biotech company in Cambridge, Massachusetts. In early October it announced the first participant had been dosed with PM577a, an experimental therapy for Wilson's disease. One patient so far — and no results yet. First data are expected in 2027.
Search-and-Replace, Not Scissors
Standard CRISPR–Cas9 edits DNA by cutting it — molecular scissors that snip both strands of the double helix. Prime editing works more like a word processor's find-and-replace: guided to one exact address, it rewrites the faulty letters directly, without cutting both strands. That is why researchers see it as more precise, with fewer unwanted changes.
Think of it this way: CRISPR cuts the page. Prime editing corrects the typo.
Why Wilson's Disease
Wilson's disease is a rare inherited disorder caused by mutations in ATP7B, a gene whose protein escorts excess copper out of the liver. When it fails, copper piles up — in the liver first, then the brain, kidneys and eyes. Current drugs must be taken daily for life; the only cure is a liver transplant.
PM577a aims at the root. Tiny fat particles carry the editors through a single infusion into liver cells, where they correct one specific typo — H1069Q, the most common Wilson's-causing ATP7B mutation in North America and Europe.
Early Days — Honestly
The Phase 1/2 trial is small and safety-first: roughly 42 adults and adolescents carrying at least one H1069Q copy, at sites in the US and New Zealand. Experts quoted in Nature urge patience: editing inside the body brings its own challenges, starting with delivering editors to the right cells. PM577a also fits only patients with this one mutation — and no in-body gene-editing therapy has been approved anywhere yet.
The Twikup Take
One patient, one infusion, zero results — so far. But if prime editing proves safe inside the body, the same trick could one day be aimed at thousands of genetic diseases. 2027 is when we start finding out.
Health note: This article describes an experimental treatment in an early-stage clinical trial. It is not medical advice, and no gene-editing therapy for Wilson's disease has been approved. Patients should consult their healthcare provider before considering any experimental treatment.
Image: AI-generated illustration.